REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 107 filers reported holding REPLIMUNE GROUP INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,305,493 | -29.9% | 76,300 | -4.9% | 0.00% | 0.0% |
| Q2 2023 | $1,862,244 | +36.4% | 80,200 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $1,365,118 | -41.5% | 77,300 | -9.9% | 0.00% | -50.0% |
| Q4 2022 | $2,333,760 | +132.2% | 85,800 | +47.4% | 0.00% | +100.0% |
| Q3 2022 | $1,005,000 | +3.4% | 58,200 | +4.7% | 0.00% | 0.0% |
| Q2 2022 | $972,000 | +14.8% | 55,600 | +11.4% | 0.00% | – |
| Q1 2022 | $847,000 | -32.2% | 49,900 | +8.2% | 0.00% | -100.0% |
| Q4 2021 | $1,249,000 | -8.6% | 46,100 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,366,000 | -22.9% | 46,100 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,771,000 | +10.5% | 46,100 | -12.2% | 0.00% | 0.0% |
| Q1 2021 | $1,602,000 | -17.3% | 52,500 | +3.3% | 0.00% | 0.0% |
| Q4 2020 | $1,938,000 | +242.4% | 50,800 | +106.5% | 0.00% | – |
| Q3 2020 | $566,000 | -7.4% | 24,600 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $611,000 | – | 24,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,001,319 | $51,352,568 | 47.17% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $35,901,913 | 5.56% |
| Redmile Group, LLC | 4,163,922 | $71,244,705 | 3.39% |
| Nan Fung Group Holdings Ltd | 184,739 | $3,160,884 | 2.56% |
| GREAT POINT PARTNERS LLC | 638,495 | $10,924,649 | 1.99% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $2,566,500 | 1.72% |
| Ghost Tree Capital, LLC | 250,000 | $4,277,500 | 1.41% |
| Altium Capital Management LP | 155,000 | $2,652,050 | 1.38% |
| ACUTA CAPITAL PARTNERS, LLC | 1,000 | $1,766,000 | 1.18% |
| Camber Capital Management LP | 2,000,000 | $34,220 | 1.13% |